Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-02-14 10:02 am Purchase | 13G | PTC Therapeutics, Inc. PTCT | RTW INVESTMENTS LP | 5,615,387 7.7% | 321,421 (+6.07%) | View |
| 2023-02-09 12:31 pm Purchase | 13G | PTC Therapeutics, Inc. PTCT | FMR LLC | 10,782,306 14.999% | 177,621 (+1.67%) | View |
| 2023-02-09 11:49 am Sale | 13G | PTC Therapeutics, Inc. PTCT | JANUS HENDERSON GROUP PLC JHG | 2,027,142 2.8% | -1,874,255 (-48.04%) | View |
| 2023-02-09 11:30 am Purchase | 13G | PTC Therapeutics, Inc. PTCT | VANGUARD GROUP INC | 7,339,520 10.21% | 155,828 (+2.17%) | View |
| 2023-02-06 2:56 pm Sale | 13G | PTC Therapeutics, Inc. PTCT | WELLINGTON MANAGEMENT GROUP LLP | 7,430,907 10.34% | -724,140 (-8.88%) | View |
| 2023-02-01 11:48 am Sale | 13G | PTC Therapeutics, Inc. PTCT | FRANKLIN RESOURCES INC BEN | 3,489,687 4.8% | -1,391,527 (-28.51%) | View |
| 2023-01-24 1:56 pm Purchase | 13G | PTC Therapeutics, Inc. PTCT | BlackRock Inc. BLK | 6,640,854 9.2% | 250,913 (+3.93%) | View |
| 2022-07-11 1:13 pm Purchase | 13G | PTC Therapeutics, Inc. PTCT | VANGUARD GROUP INC | 7,183,692 10.07% | 294,783 (+4.28%) | View |
| 2022-02-14 08:00 am Purchase | 13G | PTC Therapeutics, Inc. PTCT | RTW INVESTMENTS LP | 5,293,966 7.5% | 325,757 (+6.56%) | View |
| 2022-02-11 3:08 pm Purchase | 13G | PTC Therapeutics, Inc. PTCT | JANUS HENDERSON GROUP PLC JHG | 3,901,397 5.5% | 3,901,397 (New Position) | View |
| 2022-02-11 10:25 am Sale | 13G | PTC Therapeutics, Inc. PTCT | HARTFORD MUTUAL FUNDS INC | 0 0% | -4,084,279 (Position Closed) | View |
| 2022-02-10 08:32 am Purchase | 13G | PTC Therapeutics, Inc. PTCT | VANGUARD GROUP INC | 6,888,909 9.74% | 687,942 (+11.09%) | View |
| 2022-02-09 10:24 am Purchase | 13G | PTC Therapeutics, Inc. PTCT | FMR LLC | 10,604,685 15% | 365,530 (+3.57%) | View |
| 2022-02-07 1:52 pm Sale | 13G | PTC Therapeutics, Inc. PTCT | FRANKLIN RESOURCES INC BEN | 4,881,214 6.9% | -694,969 (-12.46%) | View |
| 2022-02-04 09:22 am Sale | 13G | PTC Therapeutics, Inc. PTCT | WELLINGTON MANAGEMENT GROUP LLP | 8,155,047 11.54% | -1,183,832 (-12.68%) | View |
| 2022-02-02 7:11 pm Purchase | 13G | PTC Therapeutics, Inc. PTCT | BlackRock Inc. BLK | 6,389,941 9% | 361,822 (+6.00%) | View |
| 2021-03-02 4:45 pm Purchase | 13D | ClearPoint Neuro Inc. MRIC | PTC THERAPEUTICS INC. PTCT | 2,961,245 14% | 4,255 (+0.14%) | View |
| 2021-02-26 11:44 am Purchase | 13G | PTC Therapeutics, Inc. PTCT | RTW INVESTMENTS LP | 4,968,209 7.28% | 746,373 (+17.68%) | View |
| 2021-02-16 12:23 pm Sale | 13G | PTC Therapeutics, Inc. PTCT | PRICE T ROWE ASSOCIATES INC | 2,215,017 3.2% | -1,822,970 (-45.15%) | View |
| 2021-02-12 09:34 am Purchase | 13G | PTC Therapeutics, Inc. PTCT | RTW INVESTMENTS LP | 4,221,836 6.19% | 389,356 (+10.16%) | View |